Drug application
TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER (AMINO ACIDS, DEXTROSE, MAGNESIUM CHLORIDE and 3 more)
Drugs@FDA NDA 020147 · BAXTER HLTHCARE
Key facts
| Drug name | TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER |
|---|---|
| Active ingredients | AMINO ACIDS, DEXTROSE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, SODIUM ACETATE, SODIUM CHLORIDE |
| Application type | NDA |
| Application number | 020147 |
| Company | BAXTER HLTHCARE |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 2.75%;5GM/100ML;51MG/100ML;261MG/100ML;216MG/100ML;112MG/100ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Oct 23, 1995 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 10–99 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: